TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
18 hedge funds and large institutions have $6.93M invested in Talis Biomedical Corporation Common Stock in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$90K | |
| 2 | +$16.3K | |
| 3 | +$5.34K | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$2.63K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$149 |
Top Sellers
| 1 | -$74.7K | |
| 2 | -$50.1K | |
| 3 | -$12.1K | |
| 4 |
Morgan Stanley
New York
|
-$936 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$534 |